NYSE: CVECenovus Energy Inc Stock
$11.77-0.35 (-2.89%)
Updated Apr 30, 2025
CVE Price
$11.77
Fair Value Price
N/A
Market Cap
$21.48B
52 Week Low
$10.23
52 Week High
$21.08
P/E
9.95x
P/B
1.03x
P/S
0.74x
PEG
0.41x
Dividend Yield
6.75%
Revenue
$38.22B
Earnings
$2.18B
Gross Margin
19.9%
Operating Margin
8.45%
Profit Margin
5.8%
Debt to Equity
0.9
Operating Cash Flow
$6B
Beta
1.13
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CVE Overview
Cenovus Energy Inc. produces crude oil, natural gas liquids, and natural gas from oils sands assets in Alberta, Canada, with refining operations in the U.S. Cenovus was formed in 2009 when Encana Corporation split. Cenovus Energy is headquartered in Calgary, Alberta.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CVE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil & Gas Integrated
Industry Rating
D
CVE
Ranked#11 of 15
Ranked#11 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $25.43 | A | |
| $76.78 | C | |
| $8.11 | C |
Be the first to know about important CVE news, forecast changes, insider trades & much more!
CVE News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CVE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CVE ($11.77) is trading below its intrinsic value of $16.94, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CVE is good value based on its earnings relative to its share price (9.95x), compared to the US market average (29.18x)
P/E vs Market Valuation
CVE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CVE due diligence checks available for Premium users.
Valuation
CVE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
9.95x
Industry
4.78x
Market
29.18x
CVE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CVE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CVE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.03x
Industry
1.37x
CVE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CVE price to earnings growth (PEG)
For valuing profitable companies with growth potential
CVE is good value based... subscribe to Premium to read more.
PEG Value Valuation
CVE's financial health
Profit margin
Revenue
$8.2B
Net Income
$101.4M
Profit Margin
1.2%
CVE's Earnings (EBIT) of $3.23B... subscribe to Premium to read more.
Interest Coverage Financials
CVE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$39.3B
Liabilities
$18.6B
Debt to equity
0.9
CVE's short-term assets ($7.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CVE's long-term liabilities ($13.67B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CVE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CVE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.4B
Investing
-$1.1B
Financing
-$514.6M
CVE's operating cash flow ($6.50B)... subscribe to Premium to read more.
Debt Coverage Financials
CVE vs Oil & Gas Integrated Stocks
Cenovus Energy Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.